Proton Pump Inhibitors and Cancer Risk - Quiz - MDSpire

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

By
Kathryn Wighton
February 19, 2026
3 min

Conexiant

Share

Original Source(s)

Conexiant

Proton Pump Inhibitors and Cancer Risk

by Kathryn Wighton
February 19, 2026

Related Content

Frontiers In Immunology

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

by Arianna Dal Buono, Olga Maria Nardone, Rocio Ferreiro-Iglesias
June 17, 2026

Frontiers In Immunology

Spatial genetic mapping links shared inflammatory bowel disease liability to adult immune–epithelial lesion contexts

by Guangyi Tao, Hanzhe Du, Jun Zhao, Zhonghe Zeng, Junwu Cui, Longming Lei
July 8, 2026

Int. Journal Of Computer Assisted Radiology And Surgery

ESD-VesNet: uncertainty-aware vessel segmentation network for endoscopic submucosal dissection with hard negative mining